Isabelle Krakowski

Artiklar

Article: BRITISH JOURNAL OF DERMATOLOGY. 2023;188(1):32-40
Association of metformin use and survival in patients with cutaneous melanoma and diabetes
Krakowski I; Habel H; Nielsen K; Ingvar C; Andersson TML; Girnita A; Smedby KE; Eriksson H
Article: CANCERS. 2021;13(16):4164
Clinical Categorization Algorithm (CLICAL) and Machine Learning Approach (SRF-CLICAL) to Predict Clinical Benefit to Immunotherapy in Metastatic Melanoma Patients: Real-World Evidence from the Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy
Madonna G; Masucci GV; Capone M; Mallardo D; Grimaldi AM; Simeone E; Vanella V; Festino L; Palla M; Scarpato L; Tuffanelli M; D'angelo G; Villabona L; Krakowski I; Eriksson H; Simao F; Lewensohn R; Ascierto PA
Article: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(1):105-115
Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting
Krakowski I; Bottai M; Habel H; Masucci G; Girnita A; Smedby KE; Eriksson H
Article: CANCERS. 2020;12(11):E3228-3228
The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study
Katsarelias D; Eriksson H; Mikiver R; Krakowski I; Nilsson JA; Ny L; Olofsson Bagge R

Thesis / dissertation: 2024
Strategies for improving melanoma survival : from early detection to therapies for advanced disease
Krakowski I
Review: NPJ DIGITAL MEDICINE. 2024;7(1):78
Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis
Krakowski I; Kim J; Cai ZR; Daneshjou R; Lapins J; Eriksson H; Lykou A; Linos E
Corrigendum: JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2021;35(6):1407
Impact of modern systemic therapies and clinical markers on treatment outcome for metastatic melanoma in a real-world setting (vol 35, pg 105, 2021)
Krakowski I; Bottai M; Habel H; Masucci G; Girnita A; Smedby KE; Eriksson H
Editorial comment: CANCERS. 2020;13(1):E92-92
Reply to Comment on Katsarelias, D., et al. "The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study." Cancers 2020, 12, 3228
Katsarelias D; Eriksson H; Mikiver R; Krakowski I; Nilsson JA; Ny L; Olofsson Bagge R
Letter: ALLERGY. EUROPEAN JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2020;75(8):2096-2099
Desloratadine and loratadine use associated with improved melanoma survival
Fritz I; Wagner P; Bottai M; Eriksson H; Ingvar C; Krakowski I; Nielsen K; Olsson H